The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia.
Saved in:
| Title: | The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia. |
|---|---|
| Authors: | Byrne M; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Danielson N; Tennessee Valley Healthcare System, Nashville, Tennessee, USA., Sengsayadeth S; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Tennessee Valley Healthcare System, Nashville, Tennessee, USA., Rasche A; Department of Nursing, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Culos K; Department of Pharmacy, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Gatwood K; Department of Pharmacy, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Wyatt H; Department of Pharmacy, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Chinratanalab W; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Tennessee Valley Healthcare System, Nashville, Tennessee, USA., Dholaria B; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Ferrell PB; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Fogo K; Department of Nursing, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Goodman S; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Tennessee Valley Healthcare System, Nashville, Tennessee, USA., Jagasia M; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Jayani R; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Kassim A; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Mohan SR; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Savani BN; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Strickland SA; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Engelhardt BG; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Savona M; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.; Program in Cancer Biology, Vanderbilt University, Nashville, Tennessee, USA. |
| Source: | American journal of hematology [Am J Hematol] 2020 Sep; Vol. 95 (9), pp. 1006-1014. Date of Electronic Publication: 2020 Jun 15. |
| Publication Type: | Clinical Trial; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1096-8652 |
|---|---|
| DOI: | 10.1002/ajh.25859 |
